Each April, Alcohol Awareness Month serves as an important reminder to recognize the impact alcohol can have on overall health and well-being. This observance encourages individuals, healthcare providers, and communities to increase awareness of alcohol-related health risks and emphasize prevention, early detection, and support.
ACON Laboratories, Inc., a leading global medical device manufacturer, announced today that its Flowflex® Plus RSV + Flu A/B + COVID Home Test has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). The Flowflex Plus RSV + Flu A/B + COVID Home Test (K251749) is an over-the-counter (OTC) rapid antigen test that can be administered in the comfort and privacy of consumers’ homes. This new test will be manufactured domestically in ACON’s state-of-the-art facility in San Diego, CA.
